Evidence map›Paper›PMID 40843339›Full record

ArticlePatterns (New York, N.Y.)2025

BioLLM: A standardized framework for integrating and benchmarking single-cell foundation models.

Ping Qiu, Qianqian Chen, Hua Qin, Shuangsang Fang, Yilin Zhang, Yanlin Zhang, Tianyi Xia, Lei Cao, Yong Zhang, Xiaodong Fang and 2 more

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ping QiuCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Qianqian ChenBGI Research, Beijing 102601, China.
Hua QinBGI Research, Beijing 102601, China.
Shuangsang FangBGI Research, Beijing 102601, China.
Yilin ZhangBGI Research, Beijing 102601, China.
Yanlin ZhangDSA Thrust, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, China.
Tianyi XiaBGI Research, Beijing 102601, China.
Lei CaoBGI Research, Beijing 102601, China.
Yong ZhangBGI Research, Wuhan 430074, China.
Xiaodong FangBGI Research, Shenzhen 518083, China.
Yuxiang LiBGI Research, Wuhan 430074, China.
Luni HuBGI Research, Beijing 102601, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application and evaluation of single-cell foundation models (scFMs) present significant challenges due to heterogeneous architectures and coding standards. To address this, we introduce BioLLM (biological large language model), a unified framework for integrating and applying scFMs to single-cell RNA sequencing analysis. BioLLM provides a unified interface that integrates diverse scFMs, eliminating architectural and coding inconsistencies to enable streamlined model access. With standardized APIs and comprehensive documentation, BioLLM supports streamlined model switching and consistent benchmarking. Our comprehensive evaluation of scFMs revealed distinct strengths and limitations, highlighting scGPT's robust performance across all tasks, including zero shot and fine-tuning. Geneformer and scFoundation demonstrated strong capabilities in gene-level tasks, benefiting from effective pretraining strategies. In contrast, scBERT lagged behind, likely due to its smaller model size and limited training data. Ultimately, BioLLM aims to empower the scientific community to leverage the full potential of foundational models, advancing our understanding of complex biological systems through enhanced single-cell analysis.

Indexed as

model benchmarkingsingle-cell foundation modelsunified frameworkzero shot and fine-tuning

Identifiers

PMID40843339
PMCPMC12365531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.